Navigation Links
Idenix Pharmaceuticals to Present at the JP Morgan 26th Annual Healthcare Conference
Date:12/20/2007

CAMBRIDGE, Mass., Dec. 20 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview, including an update of the company's HCV and HIV discovery and development programs, at the upcoming JP Morgan 26th Annual Healthcare Conference on Tuesday, January 8, 2008 at 2:30 p.m. PT at the Westin St. Francis Hotel in San Francisco.

The live and archived webcasts of the presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 995-9905

Investors: Amy Sullivan (617) 995-9838


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... a bigger thrill when on an emotional rollercoaste...althDay News) -- Call it the fear factor meets the...at spectators -- especially those who root for the...f it,s a closely contested match and victory was i...air. , Chew on that this Thanksgiving weekend a...
(Date:11/26/2009)... Research Triangle Dental (RTDent...rth Carolina, today announced the expansion of its...NEER Dentist, Dr. Doug Macmillan. , ...gle Dental is pleased to announce that Dr. Doug Ma...tly completed an additional advanced training semi...
(Date:11/25/2009)...EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmos...utachiropractorcanalsogivepatientsthehelptheyneed....reyourjaw(mandible)contacts/connectswithyourskull(...edwithTMJdysfunctionarepainwithchewing,clickingorp...TMJdysfunctionincluding:headaches,fatigue,sleepdis...
(Date:11/25/2009)...TORONTOandCALGARY,Nov.25/PRNewswire/-SentinelleMed...aging(MRI)coilsandsoftwareandCalgaryScientificInc....veintroducedawebversionofAegis(TM)Breast4DAdvanced...ceisthefirsttrulyzero-footprintWebclientbasedmedic...reWeb(TM)platformallowsforzero-footprintaccess-req...
(Date:11/25/2009)...SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--An...erforDrugEvaluationandResearch,titled"ADifficultBa...intheNov.26,2009issueofTheNewEnglandJournalofMedic...rnh/20090824/FDALOGO ) ,, Inthearticle,Woodcock...painmedicationforthosewhoneeditandmanagingtherisks...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...eems that Paris Hilton is making all possible arra...rison interview. According to sources, th...ng released on June 26, is pamper her dry face. ...ing dry. So, the heiress has booked a faci...
...ents with radiation retinopathy who were destined ...ight longer through localized treatment with Avast...year study published in the June, 2007 Archives of...nopathy, said Paul T. Finger, MD, lead author of t...
...thousand turkeys at a Czech farm where the potenti...this week have been slaughtered, officials said on...en killed and the process is underway for the smal...Friday)," he added. The H5N1 strain of bird fl...
...ue fever has infected almost 20,000 people in Viet... 21, seven more than in the same period last year,...eratures and rainfalls have been blamed for the ne...lta. Malaysia and other Southeast Asian count...
...archers have formed a new compound AN2690, that mi...in nails by blocking an enzyme crucial for the pro...udy was conducted by a team of researchers includi...oble, France. AN2690 interferes with an enz...
...force, an Anglo-American company has been allowed ...ases in future by the US Food and Drug Administrat...ells of the immune system that defend the body aga...s and will extract the white blood cells to store ...
Other Medicine News:Health News:Untreatable Eye Disease Improves With Avastin 2Health News:Researchers Devise New Compound to Treat Fungal Infections 2
(Date:11/25/2009)...GO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(Nas...ngproductsforminimallydisruptivesurgicaltreatments...ecallonMonday,November30,2009,at5:30p.m.ET/2:30p.m...ivetoreimbursementfortheCompany,sproductsandwillin...nandanswersession.Thedial-innumbersare1-877-407-40...
(Date:11/25/2009)...GHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall/--...,aleadinginnovatorandprovideroflessinvasive,miniat...gthetreatmentofadvancedheartfailure,todayannounced...21stAnnualPiperJaffrayHealthCareConferenceat8:00am...heldattheNewYorkPalaceHotel,December1-2. ,, Ali...
(Date:11/24/2009)...N,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagnost...derofdiagnostictesting,informationandservices,anno...affrayHealthcareConferenceinNewYorkCity.Thepresent....m.EasternTime. ,, Duringtheconference,thecompa...roximate3%,operatingincometoexceed18%ofrevenues,an...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2New strategy for mending broken hearts 3F 10316 1New strategy for mending broken hearts 3F 10316 2Poor Education May Lead to Poor Health 59258 1Poor Education May Lead to Poor Health 59258 2Poor Education May Lead to Poor Health 59258 3Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 1Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 2Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 3
...S, N.J., June 20, 2007 /PRNewswire-USNewswire/ -- ...the national,non-profit organization dedicated to...ries and improving the lives of people living,with...in President,Bush,s veto of the Stem Cell Research...or advancements in stem cell research with the,sup...
...alif.--(BUSINESS WIRE)--Jun 20, 2007 - Materia, In... the licensing of its,metathesis platform to Eisai...any, for use in drug discovery and development.,Th...to discover,develop, and patent pharmaceutical co...catalysts and associated intellectual property., M...
Other Medicine Technology:The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 2The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 3Materia Licenses Metathesis Catalyst Platform to Eisai 2
7.5mm Trephine Handle
1.0mm Trephine with Handle
8.5mm Calibrated Trephine Handle
9.0mm Calibrated Trephine Handle
Medicine Products: